Covered Stocks

Jim Molloy

Work

Analyst Jim Molloy works at ALLIANCE GLOBAL PARTNERS and is focused on the Healthcare sector with 17 price targets and ratings documented since 2016 spanning on 3 stocks. Analyst's average stock valuation to be materialised ratio is 33.33% with an average time for price targets to be met of 15.67 days.

Most recent stock forecast was given on TNXP, Tonix Pharmaceuticals Holding Corp at 12-Jan-2023.

Jim Molloy best performing recommendations are on ICPT (INTERCEPT PHARMACEUTICALS, INC).
The best stock recommendation documented was for ICPT (INTERCEPT PHARMACEUTICALS, INC) at 5/5/2017. The price target of $115 was fulfilled within 3 days with a profit of $3.74 (3.15%) receiving and performance score of 10.5.

Average potential price target upside

ICPT HTBX TNXP

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

26

$7.6 (41.30%)

27

9 days ago

1/14 (7.14%)

$27.67 (69.79%)

90

Hold

14

$-4.4 (-23.91%)

16

2 months 13 days ago

2/2 (100%)

$-0.97 (-6.13%)

32

Hold

17

$-1.4 (-7.61%)

21

3 months 26 days ago

3/6 (50%)

$1.53 (25.80%)

99

Buy

35

$16.6 (90.22%)

52

3 months 26 days ago

3/18 (16.67%)

$134.4 (162.79%)

48

Buy

28

$9.6 (52.17%)

32

5 months 7 days ago

1/15 (6.67%)

$34.2 (68.57%)

9

Show more analysts
ICPT HTBX TNXP